Cancer and Cardiovascular Disease by Yusuf, Syed Wamique et al.
SAGE-Hindawi Access to Research
Cardiology Research and Practice
Volume 2011, Article ID 943748, 1 page
doi:10.4061/2011/943748
Editorial
CancerandCardiovascular Disease
Syed WamiqueYusuf,1 CarloCipolla,2 Jean-BernardDurand,1 andDanielJ. Lenihan3
1Department of Cardiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1451, Houston,
TX 77030, USA
2Cardiology Unit, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
3Division of Cardivascular Medicine, Vanderbilt University, 1215 21th Avenue South, Nashville, TN 37232, USA
Correspondence should be addressed to Syed Wamique Yusuf, syusuf@mdanderson.org
Received 29 June 2011; Accepted 29 June 2011
Copyright © 2011 Syed Wamique Yusuf et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Cancer and cardiovascular disease (CVD) are the two most
common causes of mortality and morbidity worldwide. The
incidence ofboth cancerandcardiovasculardisease increases
with age. With increased life expectancy, the burden of
both these diseases will increase substantially over the next
generation. Advancement in cancer therapy and supportive
care has led to increasing number of survivors of childhood
cancer. Seventy percent of the children diagnosed with
malignancy before the age of 15 years will have a disease-
free 5-year survival from diagnosis. Cancer is now being
recognized as a chronic disease as evidenced by a growing
numberofcancersurvivorsthatcurrentlyexceeds11million.
With further improvement in cancer therapy, this number
will likely increase in years to come. As the numbers of
survivors grow so does the number of patients living with
the late eﬀects of cancer-related cardiotoxicity. Amongst
Hodgkin lymphoma patients who have received radiation,
CVD is one of the most common causes of death.
Physicians and ancillary staﬀ frequently have to take
care of patients with concomitant cancer and cardiovascular
disease. Some cardiac diseases predates the diagnosis of
cancer,whereasother conditions like chemotherapy-induced
cardiomyopathy and radiation-related heart disease are
directly related to the cardiotoxic side eﬀects of cancer ther-
apy. The cardiotoxic side eﬀects of agents like 5-ﬂuouracil,
adriamycin, and tyrosine kinase inhibitors are well known.
However, the cardiotoxic proﬁles of newer investigational
chemotherapeutic agents are largely unknown.
Chemotherapy frequently induces thrombocytopenia,
which in itself poses therapeutic challenge in the manage-
ment of conditions like acute coronary syndrome, atrial
ﬁbrillation, stroke, and prosthetic valves. Evidence-based
treatment of cardiovascular disease in cancer patients is
lacking largely because all cardiology trials have excluded
patients with cancer and similarly cancer trials have excluded
patients with signiﬁcant cardiovascular comorbidity.
Whilerecentlysomesingle-centerstudieshaveshownthe
eﬃcacy of medications like ace inhibitors and beta blockers
forthetreatmentofchemotherapy-inducedcardiomyopathy,
evidence-based treatment of other major cardiovascular
diseases in cancer patients is not well established.
Inthisissueofcancerandcardiovasculardisease,wehave
covered some common conditions like venous thrombosis,
cardiovascular eﬀects of radiation therapy, cardiovascular
eﬀects of anthracycline in childhood cancer survivors, and
management of aortic aneurysm in cancer patients. The use
of newer modality, like computed tomographic angiography,
may provide a pivotal role in the investigation of cancer
patients with concomitant cardiac problem, as outlined in
a clinical investigation in this journal. The case reports
presented are some conditions that are unique to cancer
population. Cardio-oncology is a growing ﬁeld, and we are
encouraged by the number of submissions to our special
edition.Wehopethatthereaderswillﬁndthisspecialedition
useful in their clinical practice.
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